Racial and Socioeconomic Disparities in Pediatric Heart Transplant Outcomes in the Era of Anti-Thymocyte Globulin Induction

被引:0
|
作者
Carlo, W. F. [1 ]
Padilla, L. A. [2 ]
Xu, W. [3 ]
Carboni, M. P. [4 ]
Kleinmahon, J. A. [5 ]
Sparks, J. D. [6 ]
Rudraraju, R. [7 ]
Villa, C. [8 ]
Singh, T. P. [9 ]
机构
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Alabama Birmingham, Surg, Birmingham, AL USA
[3] Arkansas Childrens Hosp, Pediat Cardiol, Little Rock, AR USA
[4] Duke Univ, Pediat Cardiol, Durham, NC USA
[5] Ochsner Hlth, Cardiol, New Orleans, LA USA
[6] Norton Childrens Hosp, Pediat, Louisville, KY USA
[7] Univ Alabama Birmingham, Kirklin Inst Res Surg Outcomes, Birmingham, AL USA
[8] Cincinnati Childrens Hosp, Cardiol, Med Ctr, Cincinnati, OH USA
[9] Boston Childrens Hosp, Cardiol, Boston, MA USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
203
引用
收藏
页码:S96 / S97
页数:2
相关论文
共 50 条
  • [41] Characterization of CD3-Guided Anti-Thymocyte Globulin Dose Minimization for Renal Sparing Induction after Heart Transplant
    Lange, J.
    Waldman, G.
    Scalzo, R.
    Lewis, G.
    Tsao, L.
    Clark, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S495 - S495
  • [42] Anti-thymocyte globulin induction therapy usage is not associated with short and long-term survival differences in heart transplant patients
    Jia, S.
    Nagpal, D.
    Goldraich, L.
    Davey, R. A.
    Mckelvie, R.
    De, S.
    Smith, S. J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 280 - 280
  • [43] Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation
    Flaman, Flavia
    Zieroth, Shelley
    Rao, Vivek
    Ross, Heather
    Delgado, Diego H.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (11): : 1358 - 1362
  • [44] Challenging Dogma That Anti-Thymocyte Globulin Induction with Delayed Calcineurin Inhibitor Benefits Patients with Renal Insufficiency Undergoing Heart Transplant
    Kittleson, M.
    Patel, J.
    Chang, D.
    Kransdorf, E.
    Geft, D.
    Nishihara, K.
    Shen, A.
    Velleca, A.
    Czer, L.
    Esmailian, F.
    Kobashigawa, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 366 - 367
  • [45] Anti-Thymocyte Globulin and Impact of Gender on Allogeneic Stem Cell Transplant
    Farhan, Shatha
    Pelland, Danielle
    Peres, Edward
    Janakiraman, Nalini
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [46] THYROTOXICOSIS RELATED TO ANTI-THYMOCYTE GLOBULIN (ATG) IN A RENAL TRANSPLANT RECIPIENT
    Manickam, Hema
    Sultan, Ghayyath
    Riley, Daniel
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 65 (04) : A57 - A57
  • [47] Comparison of 10-year graft failure rates after induction with basiliximab or anti-thymocyte globulin in pediatric heart transplant recipients-The influence of race
    Carlo, Waldemar F.
    Bryant, Roosevelt, III
    Zafar, Farhan
    PEDIATRIC TRANSPLANTATION, 2019, 23 (03)
  • [48] Anti-thymocyte Globulin versus Basiliximab Induction in Renal Transplant Recipients: Long-term Outcome
    Kesiraju, Sailaja
    Paritala, Purna
    Rao, Uma Maheswara Ch
    Athmakuri, Srinivasa Murthy
    Reddy, V. S.
    Sahariah, S.
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2014, 25 (01) : 9 - 15
  • [49] Use of rabbit anti-thymocyte globulin for induction immunosuppression in high-risk kidney transplant recipients
    Belitsky, P
    MacDonald, AS
    Lawen, J
    McAlister, V
    BitterSuermann, H
    Kiberd, B
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (7A) : S16 - S17
  • [50] DUAL INDUCTION WITH ANTI-THYMOCYTE GLOBULIN(ATG) AND RITUXIMAB(RTX) IN SENSITIZED KIDNEY TRANSPLANT(KT) PATIENTS
    Kong, Jin
    Jeong, Joon
    Yoon, Chul
    Whang, Eun
    Son, Sung
    Kwon, Hyuk
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33